Hemophilia is a rare bleeding disorder characterized by low levels of proteins called “clotting factors.” Hemophilia is an inherited blood disorder in which your blood does not clot properly ...

Hemophilia is a serious condition that can limit the ability to avoid episodes of bleeding. Treatment includes regular infusions of proteins to replace what the body doesn’t produce naturally ...

Pfizer (PFE) will end global development and commercialization of Beqvez, a gene therapy for hemophilia, Nikkei learned Thursday, after the drugmaker dropped its other similar treatment for the ...

Hemophilia A is characterized by FVIII deficiency, leading to joint bleeds and chronic pain despite prophylactic therapy. Treatment options vary in sustaining FVIII levels, with gene therapy and ...

Total knee replacement is an operation frequently needed by hemophilia patients, which greatly improves their quality of life. This operation, however, carries a higher risk of bleeding and ...

It is almost exclusively found in males. According to the World Federation of Hemophilia, more than 38,000 people worldwide were living with haemophilia B in 2021. Pfizer's BENEGENE-2 study met ...